Diarylheptanoid and SAR-CoV-2

The recent outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has posed a serious challenge to mankind. The need for an urgent cure for SARS-CoV-2 increased, as there was no specific treatment protocol designed for this global pandemic. Previous studies show similarities in the genomic structure of SARS-CoV-2 and SARS-CoV. So, the treatment strategy applied for SARS-CoV can be applied on SARS-CoV-2 as well. This chapter focuses on the effectiveness of diarylheptanoids against SARS-CoV-2. © 2023 Elsevier Inc. All rights reserved.